Oxidative stress is a metabolic disorder in which unstable molecules, also called reactive species, cause cellular injury due to oxidation-reduction reactions with organic molecules, such as phospholipids, proteins and DNA. These injuries can lead to loss of cellular function and, consequently, important dysfunctions in organic systems. These species are constantly formed in the normal cellular physiology, either through the metabolism of oxygen or amino acids, generating, respectively, reactive oxygen species (EROS) and reactive nitrogen species (RNSN). Due to the toxic potential of these molecules, endogenous and exogenous protective mechanisms, represented by the antioxidant agents, come into action to neutralize these compounds and prevent cellular injury. When the production of these species exceeds the antioxidant capacity of the organism, the cellular metabolism enters into oxidative stress. In certain cases, the EROS and ERNS productions become desirable, as an example in inflammatory disorders, where they will participate in the production of inflammatory mediators, but the exacerbation of this production can be detrimental and it is important to know the oxidative status to control the progression of the disorder in sick animals. In this context, it is necessary to know the biochemical profile of oxidative and antioxidant compounds in clinical and hospital routine of small and large animals. The objective of this study was to elucidate the pathophysiological mechanisms of oxidative stress as well as the available laboratory diagnostic methods to explain the importance of oxidative stress in clinical practice, so that the determination of these compounds is included in the medical and hospital routine.
Background/Objective: Yellow fever (YF) is an acute infectious disease caused by the yellow fever virus which is transmitted by mosquitoes. Neotropical primates are susceptible to infection, which is often presented as epizootic outbreaks. The aim was to evaluate and characterize the immune response against YF in different species of neotropical primates from the Belo Horizonte Zoo. Methods: Vaccine 17DD was administered to 24 neotropical primates, with a single subcutaneous dose. Clinical exams, RNAemia, and detection of IgG and neutralizing antibodies against YFV were performed. In addition, an ethogram was performed to assess clinical changes and animal welfare. Results: At 4 days post-vaccination, RNAemia was detected in nine animals. There was seroconversion and persistence of immune response in Alouatta guariba clamitans, Sapajus xanthosternos, Saguinus imperator and Aotus infulatus. However, the vaccine was not immunogenic for Lagothrix cana. In Pithecia irrorata seroconversion did not persist long term, while the Ateles sp. had a transient immune response. No significant clinical manifestations were observed in any of the vaccinated animals. Conclusions: This study demonstrated a safe, immunogenic and persistent immune response induced by the attenuated 17DD vaccine strain in A. guariba clamitans, S. xanthosternos, S. imperator, and A. infulatus.
Crossbreed F1 Holstein x Gyr cows are proving to be a good alternative for milk production under tropical conditions. In order to contribute to that affirmative, our work focused on clarifying the metabolic patter of F1 Holstein x Gyr dairy cows during the most critical time in the lactation cycle, the transition period, and to compare their performance in two seasons. Blood sampling was performed on 15 cows during summer (January to April) and on 13 cows during winter (May to August), beginning three weeks before the estimated calving date, until 30 days relative to calving. The season had a great influence on the metabolic status. Almost all evaluated metabolites, with exception for aminotransferase (AST), non-esterified fatty acids (NEFA) and beta-hydroxybutyrate (BHBA), that have shown no variation among seasons, demonstrated a different patter between summer and winter. Liver functions were enhanced during the postpartum, with increased liver enzymes activity and increased concentration of cholesterol and BHB. Animals went through negative energy balance (NEB) and an alarming number of animals had experienced subclinical ketosis and high NEFA concentrations.
30 October 2024 in Applied Animal Behaviour Science
Como são várias as enfermidades e os distúrbios que induzem à hipercoagulabilidade e à pré-ativação de plaquetas em eqüinos. A atividade de medicamentos utilizados para controle dessas enfermidades sobre a agregação de plaquetas pode, não apenas servir para avaliar sua evolução, como também a resposta terapêutica. Com o objetivo de avaliar a prevenção e a reversão da agregação plaquetária de eqüinos in vitro foram utilizados os antiinflamatórios não esteroidais (AINES): ketoprofeno, fenilbutazona e flunixim meglumine. A comparação demonstrou que a fenilbutazona e o ketoprofeno previnem a agregação de plaquetas de eqüinos induzida pelo ADP, de forma mais eficaz do que o flunixim-meglumine e, superior ao fragmento monoclonal de anticorpo Reopro, sendo semelhante a dos bloqueadores de receptores de membrana Ro-438857 e RGDS. Quanto a reverão da agregação plaquetária tanto a fenilbutazona quanto o ketoprofeno demonstraram efeitos dose-dependente.